AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Overexpression of constitutively active Akt significantly abolishes propofol’s effects in CML cells (Fig. 3c and d), confirming that propofol acts on CML via suppression Akt/mTOR pathway.